edelfosine has been researched along with masoprocol in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Kruse, ML; Schmidt, WE; Schmidt-Choudhury, A; Schmidtmayer, J; Seebeck, J | 1 |
| Basappa, NS; Johnson-Henry, K; Sherman, PM; Soni, R; Wallace, JL; Wu, GK | 1 |
3 other study(ies) available for edelfosine and masoprocol
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Pituitary adenylate cyclase activating polypeptide induces multiple signaling pathways in rat peritoneal mast cells.
Topics: Adenylate Cyclase Toxin; Animals; Bridged-Ring Compounds; Estrenes; Indomethacin; Masoprocol; Mast Cells; Neuropeptides; Norbornanes; p-Methoxy-N-methylphenethylamine; Peritoneal Cavity; Pertussis Toxin; Phospholipid Ethers; Pituitary Adenylate Cyclase-Activating Polypeptide; Pyrrolidinones; Rats; Signal Transduction; Staurosporine; Thiocarbamates; Thiones; Virulence Factors, Bordetella | 1998 |
Inhibition of attaching and effacing lesion formation following enteropathogenic Escherichia coli and Shiga toxin-producing E. coli infection.
Topics: Actinin; Androstadienes; Bacterial Adhesion; Cell Line; Chromones; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Escherichia coli; Humans; Isoenzymes; Lipoxygenase Inhibitors; Masoprocol; Membrane Proteins; Morpholines; Nitrobenzenes; Phosphoinositide-3 Kinase Inhibitors; Phospholipid Ethers; Prostaglandin-Endoperoxide Synthases; Shiga Toxin; Signal Transduction; Sulfonamides; Type C Phospholipases; Wortmannin | 2001 |